New potential drug target for Alzheimer's disease: Rensselaer researchers find new potential drug target for Alzheimer's disease

Tau protein is implicated in many neurogenerative diseases, including Alzheimer's. New findings point to a new potential drug target to slow the progress of the disease: the enzymes responsible for sulfation called heparan sulfate 3-O transferases.

Related Keywords

Jing Zhao ,Fujian ,China ,United States ,Robertj Linhardt ,Jian Liu ,James Gibson ,Lianchun Wang ,Rensselaer Shirley Ann Jackson ,Guowei Su ,Dylan Mah ,Yongmei Xu ,Eduardo Stancanelli ,Deepak Vashishth ,Rensselaer Polytechnic Institute Ashely Canning ,Phd Center ,China Agricultural University ,University Of North Carolina At Chapel Hill ,University Of South Florida ,Apoe Christchurch ,Shirley Ann Jackson ,Interdisciplinary Studies ,Rensselaer Polytechnic Institute ,Ashely Canning ,Fuming Zhang ,Xuehong Song ,South Florida ,Glycan Therapeutics ,North Carolina ,